Biotechnology News

February 23, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River to present at upcoming investor conferences

February 23, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that it is offering shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by Celldex. The offering...

February 23, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced its results for the fourth quarter and year ended December 31, 2011. Net sales were $151.5 million and $579.0 million for the fourth...

February 23, 2012

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, today reported financial results for its fourth...

February 23, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its fourth quarter and year...

February 23, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that management will present at the following upcoming investor conferences. RBC Capital Markets’ 2012 Global Healthcare Conference Tuesday, February 28, 2012...

February 23, 2012

WINTER PARK, Fla.--(BUSINESS WIRE)--Ascendx Spine™ (www.ascendxspine.com) announced today that it has received FDA clearance to market in the United States its Acu-Cut...

February 23, 2012

NEW YORK--(BUSINESS WIRE)--In the course of its ongoing surveillance efforts, Fitch upgrades to 'BB' from 'BB-' the following bond issued on behalf of Appalachian Regional Healthcare (ARH): --$61,545,000 Kentucky Economic Development Finance...

February 23, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2011. The Form 20-F is available on Elan's website at...

February 23, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the RBC Capital Markets' Healthcare Conference. The live presentation will occur at 11:...

February 23, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is monitoring the outstanding progress of the 3rd Self-Medicated Cannabis Patient...

February 23, 2012

PETAH-TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma

February 23, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

February 23, 2012

NISKAYUNA, N.Y.--(BUSINESS WIRE)--GE and InDevR scientists developing breakthrough device to improve the diagnosis of flu at the point-of-care.

February 23, 2012

TOKYO--(BUSINESS WIRE)--Asia's largest bio event held annually in Tokyo: INT'L BIO FORUM & BIO EXPO JAPAN will be renewed as "BIO tech 2012", which consists of Partnering, Conference and Exhibition.

February 23, 2012

BOSTON--(BUSINESS WIRE)--Maxwell Biotech Venture Fund (MBVF), the first Russian venture for the life sciences sector, opens office in Boston along with RVC USA Inc.

February 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics’ (STO:PREC) partner community continues to grow with Thursby partnership Precise Biometrics today announced a partnership with Thursby Software, further enhancing Thursby’s security...

February 23, 2012

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) today announced that senior management will present at the Citi 2012 Global Health Care Conference on Monday, February 27, 2012 at 4:00 PM EST. The conference will be held at The Waldorf...

February 23, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (NVLX), reports associate SG Austria presented the success with living cell encapsulation at Cell Line Development and Engineering Asia.

February 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): For the fourth quarter, October - December · Net sales for the quarter were SEK 27.5 million (20.0), an increase of 37.5 percent year on year. The quarter’s results included full...

February 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company announced today the European Medicines Agency has accepted the filing of the marketing authorization application for once-daily oral teriflunomide for the treatment of MS.

February 23, 2012

CAMARILLO, Calif.--(BUSINESS WIRE)--PBS Biotech®, the leading supplier of novel single-use bioreactors, announces that Andrew Gengos has joined its Advisory Board.

February 23, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that Chris Boerner, Ph.D. has been promoted to Senior Vice President, Commercial. Dr. Boerner joined Seattle Genetics in November 2010 as Vice President,...

February 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free (All-Oral) Treatment Regimen of INCIVEK®, VX-222 and Ribavirin in People with Genotype 1 Hepatitis C

February 23, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces 2011 year-end results.

February 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Permeon™ Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the appointment of Katherine S. Bowdish, Ph.D., as president and chief scientific...

February 23, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen Announces Participation in New European Union Clinical Microbiology Research Consortium

February 23, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO will present a corporate update at the Citi 2012 Global Health Care Conference to be held at...

February 23, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences today reported its fourth-quarter, full-year 2011 financial results. Company management will host a webcast and call at 10 a.m. ET to discuss those results and corporate activities.

February 23, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Date and Time for Its Fourth Quarter and Fiscal Year 2011 Financial Results Conference Call

February 23, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it will present at Citi’s 2012 Global Healthcare Conference on Wednesday, February 29, 2012, at 9:30 a.m. Eastern Time at the Waldorf Astoria Hotel. Frank...

February 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s clinical...

February 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office has issued Notices of Allowance for five U.S. Patent...

February 23, 2012

SEATTLE--(BUSINESS WIRE)--The Washington Biotechnology & Biomedical Association (WBBA) was represented by Patti McKinnell Davis, Director, Public Affairs, and members of the Pacific Northwest’s life sciences community at the White House...

February 22, 2012

SEATTLE--(BUSINESS WIRE)--February 22, 2012 – Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Monday, February 27, 2012, at 9:00 a.m. ET to review fourth quarter and year-end financial results....

February 22, 2012

MARLOW, England--(BUSINESS WIRE)--Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX® and VISTABEL® (Allergan’s...

February 22, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) today announced that the Company plans to report third quarter fiscal year 2012 financial results on Form 10-Q on Thursday, March 15, 2012. Oxygen’s President &...

February 22, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Insert after first paragraph: The conference call will be hosted by senior management and will be held on Monday, February 27, 2012 at 4:30 pm Eastern time. The corrected release reads: HUMAN GENOME SCIENCES TO...

February 22, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of March: Cowen and Company’s 32nd Annual Health Care Conference on Monday, March 5, 2012...

February 22, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Citi 2012 Global Healthcare Conference

February 22, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced presentations at two upcoming...

February 22, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2011. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial...

February 22, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today reported financial results for the fourth quarter and year ended December 31, 2011. For the fourth quarter of 2011, total operating expenses were $30.6 million, compared...

February 22, 2012

CHANTILLY, Va.--(BUSINESS WIRE)--Dynex Technologies Receives SFDA Approval to Supply DS2 Automated ELISA Processing System to China. Laboratory automation firm will also establish branch office in Hong Kong.

February 22, 2012

NEW YORK--(BUSINESS WIRE)--Michael P. Simpson is the new President & CEO of Small Bone Innovations, Inc., the privately-owned orthopedic device company. Replaces Anthony G. Viscogliosi, SBI's founder, now Executive CM.

February 22, 2012

SERAING, Belgium--(BUSINESS WIRE)--Eurogentec announced today that it has successfully completed a US FDA Pre-Approval Inspection (PAI) and that it will start commercial manufacturing of a biologic for the USA market.

February 22, 2012

TORONTO--(BUSINESS WIRE)--Medworxx Inc. (“Medworxx”) (TSXV: MWX), a leader in clinical patient flow solutions, and Fujitsu Canada, a leader in Canadian healthcare consulting, announce an agreement to join forces in reducing Canadian systemic...

February 22, 2012

ZURICH & LUGANO, Switzerland--(BUSINESS WIRE)--Partnering For Global Impact® 2012 to be held In Lugano, Switzerland in July. New conference to support innovative solutions to global social and environmental challenge

February 22, 2012

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health plans to post for note holders its full-year 2011 financial results on Tuesday, February 28, 2012. The company will conduct a conference call for IMS’s note holders to review these results at 11:00 a.m...